ACPE UAN: 0475-0000-19-030-L03-P. An application based application.

Linked to EAHP Statements:

Section 4 - Clinical Pharmacy Services: Statement 4.6
Section 6 - Education and Research: Statement 6.5

Abstract

Pharmacist intervention in terms of improving safety in the use of medicines is particularly important when we come to clinical trials, due to the uncertainty in terms of efficacy and safety of investigational drugs. Pharmacist's contribution should start from informed consent administration, to dispensation, drug information and compliance evaluation. The workshop will simulate several scenarios of pharmacist's involvement with patients in the setting of a clinical trial, such as drug information at discharge, side effects and medication compliance. Simulation techniques and scenarios debriefing will be used in order to critically analyse the participants' involvement.

Learning Objectives

After the workshop, participants should be able to:
• cope with the patient in delivering information about a clinical trial and the meaning of informed consent;
• manage the correct communication approach with patients in clinical trials.

Educational need addressed

Hospital pharmacists need to know how to deal with pharmaceutical care services in clinical trials, as patient safety in this field is particularly critical, due to the uncertainty of the efficacy and safety profile of investigational drugs.

Keywords | Clinical trials, pharmaceutical care, informed consent, patient compliance.

Handouts : Barbara Brignolo Ottolini & Silvia Veronica Rossi